PHARMAORIGIN ApS
Core data
Name | PHARMAORIGIN ApS |
Address | Amaliegade 10, 1256, København K |
Founded | Nov 14, 2005 |
Employees (CVR) | 0 |
Locations (P-units) | 1View locations |
Branch | Drift af sundhedsvæsen i øvrigt i.a.n. (869900) |
Name | PHARMAORIGIN ApS |
Address | Amaliegade 10, 1256, København K |
Founded | Nov 14, 2005 |
Employees (CVR) | 0 |
Locations (P-units) | 1View locations |
Branch | Drift af sundhedsvæsen i øvrigt i.a.n. (869900) |
Keep track of PHARMAORIGIN ApS
Description
Pharmaorigin ApS is a 100% owned subsidiary of Savara ApS and part of the Savara Inc. group. Savara Inc. is a U.S.-based emerging pharmaceutical development company. The Company is focused on advancing inhalation therapies for the treatment of patients with rare pulmonary conditions. Pharmaorigin ApS has one development study, F7. There has been no development activities in Pharmaorigin ApS since the Company was bought by Savara Inc. in 2016.
Financials
| Reporting period | 2025DKK | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross profit | 0 | ||||||||
| Operating profit | 0 | ||||||||
| Profit before tax | 100,000 | ||||||||
| Net income | 100,000 | ||||||||
| Total assets | 1,477,000 | ||||||||
| Equity | 1,477,000 | ||||||||
| Avg. employees | 0 | ||||||||
2017–2025 Unlock financial history | |||||||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
No current people or role data available
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| Grant Thornton, Godkendt Revisionspartnerskab - København | AuditorMartin Bomholtz | RoleState Authorised Public Accountant | FromJun 29, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership100 % | Voting rights100 % | FromJul 15, 2016 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| 🇺🇸Savara Inc. | Ownership through | 100 % |